EORTC Quality of Life Group (QLG)
@qol.eortc.org
The EORTC Quality of Life Group (QLG) aims to better understand the effects of cancer and its treatments on health-related quality of life (HRQoL) for patients across diverse populations and cultures.
👏 Proud to be part of this important initiative, and to work together on improving how we capture and use patient perspectives in cancer trials.
📰 More about the new SISAQOL-IMI publication & online resources: www.eortc.org/blog/2025/11...
#QualityofLife #GivingVoice2Patients
@eortc.org
📰 More about the new SISAQOL-IMI publication & online resources: www.eortc.org/blog/2025/11...
#QualityofLife #GivingVoice2Patients
@eortc.org
📢 Big news from the SISAQOL-IMI Consortium! Their latest paper & new online materials are now live. This work will be key in improving how we measure patients' experiences in cancer care.
🔗 Read more in our press release: www.eortc.org/blog/2025/11...
#CancerResearch @qol.eortc.org @thelancet.com
🔗 Read more in our press release: www.eortc.org/blog/2025/11...
#CancerResearch @qol.eortc.org @thelancet.com
November 25, 2025 at 2:10 PM
👏 Proud to be part of this important initiative, and to work together on improving how we capture and use patient perspectives in cancer trials.
📰 More about the new SISAQOL-IMI publication & online resources: www.eortc.org/blog/2025/11...
#QualityofLife #GivingVoice2Patients
@eortc.org
📰 More about the new SISAQOL-IMI publication & online resources: www.eortc.org/blog/2025/11...
#QualityofLife #GivingVoice2Patients
@eortc.org
👏 Great poster by Tom Bootsma & Amirun Rahmat at #EuropeanCancerSummit on @eortc.org #QualityofLife (QoL) review underscoring the need to prioritise development & implementation of tailored QoL questionnaires that capture the lived experiences of LGBTQIA+ cancer patients.
@europeancancer.bsky.social
@europeancancer.bsky.social
November 20, 2025 at 3:32 PM
👏 Great poster by Tom Bootsma & Amirun Rahmat at #EuropeanCancerSummit on @eortc.org #QualityofLife (QoL) review underscoring the need to prioritise development & implementation of tailored QoL questionnaires that capture the lived experiences of LGBTQIA+ cancer patients.
@europeancancer.bsky.social
@europeancancer.bsky.social
📣Attending WFNOS/ #SNO2025 this week? Don't miss the rapid oral & poster presentations by @eortc.org #QualityofLife Group member Ogechukwu A. Asogwa tomorrow & Saturday on health-related quality of life in molecular glioma subtypes 👇
www.soc-neuro-onc.org/SNO2025
#NeuroOncology @neuroonc.bsky.social
www.soc-neuro-onc.org/SNO2025
#NeuroOncology @neuroonc.bsky.social
November 20, 2025 at 11:16 AM
📣Attending WFNOS/ #SNO2025 this week? Don't miss the rapid oral & poster presentations by @eortc.org #QualityofLife Group member Ogechukwu A. Asogwa tomorrow & Saturday on health-related quality of life in molecular glioma subtypes 👇
www.soc-neuro-onc.org/SNO2025
#NeuroOncology @neuroonc.bsky.social
www.soc-neuro-onc.org/SNO2025
#NeuroOncology @neuroonc.bsky.social
Reposted by EORTC Quality of Life Group (QLG)
👏 EORTC is glad to participate in the European Cancer Organisation Summit listening to leading experts on shaping the future of cancer care in Europe.
#EuropeanCancerSummit #CancerResearch
#EuropeanCancerSummit #CancerResearch
November 19, 2025 at 3:07 PM
👏 EORTC is glad to participate in the European Cancer Organisation Summit listening to leading experts on shaping the future of cancer care in Europe.
#EuropeanCancerSummit #CancerResearch
#EuropeanCancerSummit #CancerResearch
🌟 Looking forward to the upcoming SISAQOL-IMI publication 👇
#QualityofLife #GivingVoice2Patients #CancerResearch
@eortc.org
#QualityofLife #GivingVoice2Patients #CancerResearch
@eortc.org
🔎 How can we better capture what matters most to cancer patients? SISAQOL-IMI sets global standards for analysing patient-reported outcomes & #QualityofLife in cancer trials—to be published soon 👏
🎥 For more info about SISAQOL-IMI, watch the video: youtu.be/tjuoyTuClPQ?...
@qol.eortc.org
🎥 For more info about SISAQOL-IMI, watch the video: youtu.be/tjuoyTuClPQ?...
@qol.eortc.org
November 18, 2025 at 3:15 PM
🌟 Looking forward to the upcoming SISAQOL-IMI publication 👇
#QualityofLife #GivingVoice2Patients #CancerResearch
@eortc.org
#QualityofLife #GivingVoice2Patients #CancerResearch
@eortc.org
Reposted by EORTC Quality of Life Group (QLG)
👏 Earlier today at ISPOR Europe, our CEO Denis Lacombe moderated the plenary session “Pragmatic Trials — Bridging Research and Real-World Care”.
🔗 Read more: www.eortc.org/blog/2025/11...
#ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials
🔗 Read more: www.eortc.org/blog/2025/11...
#ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials
November 11, 2025 at 11:15 AM
👏 Earlier today at ISPOR Europe, our CEO Denis Lacombe moderated the plenary session “Pragmatic Trials — Bridging Research and Real-World Care”.
🔗 Read more: www.eortc.org/blog/2025/11...
#ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials
🔗 Read more: www.eortc.org/blog/2025/11...
#ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials
👏 Looking forward to @eortc.org presentations this week at #ISPOREurope, including from #QualityofLife colleague Claire Piccinin on the use of EORTC item lists in industry-sponsored studies over a 3-year period, with highlights of study attributes and trends.
More info 👇
#GivingVoice2Patients
More info 👇
#GivingVoice2Patients
November 10, 2025 at 1:25 PM
👏 Looking forward to @eortc.org presentations this week at #ISPOREurope, including from #QualityofLife colleague Claire Piccinin on the use of EORTC item lists in industry-sponsored studies over a 3-year period, with highlights of study attributes and trends.
More info 👇
#GivingVoice2Patients
More info 👇
#GivingVoice2Patients
Reposted by EORTC Quality of Life Group (QLG)
🤝 As we close #PatientDays 2025, we reflect on the powerful exchanges that took place.
This event reaffirmed the importance of integrating patient perspectives into research and care.
Thank you to all who contributed to this meaningful dialogue.
#CancerResearch #ClinicalTrials
This event reaffirmed the importance of integrating patient perspectives into research and care.
Thank you to all who contributed to this meaningful dialogue.
#CancerResearch #ClinicalTrials
November 7, 2025 at 3:41 PM
🤝 As we close #PatientDays 2025, we reflect on the powerful exchanges that took place.
This event reaffirmed the importance of integrating patient perspectives into research and care.
Thank you to all who contributed to this meaningful dialogue.
#CancerResearch #ClinicalTrials
This event reaffirmed the importance of integrating patient perspectives into research and care.
Thank you to all who contributed to this meaningful dialogue.
#CancerResearch #ClinicalTrials
Reposted by EORTC Quality of Life Group (QLG)
🎉 What a day at #EORTC #PatientDays!
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
November 6, 2025 at 4:15 PM
🎉 What a day at #EORTC #PatientDays!
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
Reposted by EORTC Quality of Life Group (QLG)
🤝 EORTC #PatientDays kicks off today in Brussels!
Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life.
🔗 Learn more: www.eortc.org/event/patien...
#CancerResearch #Oncology #ClinicalTrials
Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life.
🔗 Learn more: www.eortc.org/event/patien...
#CancerResearch #Oncology #ClinicalTrials
November 6, 2025 at 9:01 AM
🤝 EORTC #PatientDays kicks off today in Brussels!
Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life.
🔗 Learn more: www.eortc.org/event/patien...
#CancerResearch #Oncology #ClinicalTrials
Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life.
🔗 Learn more: www.eortc.org/event/patien...
#CancerResearch #Oncology #ClinicalTrials
📢 Attending #DGHO2025? Our @eortc.org #QualityofLife Group (QLG) member Bernhard Holzner is presenting an update on the QLG CTCAEplusPRO project.
🎖️ And it was selected as one of the best abstracts 👏
www.jahrestagung-haematologie-onkologie.com
#GivingVoice2Patients #DGHO #CancerResearch
🎖️ And it was selected as one of the best abstracts 👏
www.jahrestagung-haematologie-onkologie.com
#GivingVoice2Patients #DGHO #CancerResearch
October 27, 2025 at 9:47 AM
📢 Attending #DGHO2025? Our @eortc.org #QualityofLife Group (QLG) member Bernhard Holzner is presenting an update on the QLG CTCAEplusPRO project.
🎖️ And it was selected as one of the best abstracts 👏
www.jahrestagung-haematologie-onkologie.com
#GivingVoice2Patients #DGHO #CancerResearch
🎖️ And it was selected as one of the best abstracts 👏
www.jahrestagung-haematologie-onkologie.com
#GivingVoice2Patients #DGHO #CancerResearch
👏 Today & tomorrow at #ISOQOL 2025, @eortc.org #QualityofLife Group & colleagues will present 4 posters, exploring topics like ePRO implementation, side-effect burden measurement, and creating the PRO-AE inventory.
🔍 Learn more: www.eortc.org/blog/2025/10...
#GivingVoice2Patients #CancerResearch
🔍 Learn more: www.eortc.org/blog/2025/10...
#GivingVoice2Patients #CancerResearch
October 24, 2025 at 12:31 PM
👏 Today & tomorrow at #ISOQOL 2025, @eortc.org #QualityofLife Group & colleagues will present 4 posters, exploring topics like ePRO implementation, side-effect burden measurement, and creating the PRO-AE inventory.
🔍 Learn more: www.eortc.org/blog/2025/10...
#GivingVoice2Patients #CancerResearch
🔍 Learn more: www.eortc.org/blog/2025/10...
#GivingVoice2Patients #CancerResearch
🎤 Attending #ISOQOL 2025? Today, Kim Cocks will deliver an oral presentation on the update of the @eortc.org QLQ-MY20 module for multiple myeloma.
📅 Thurs 23 Oct, 13:50 CT, Session 102: Hematology
Read more ➡️ www.eortc.org/blog/2025/10...
#QualityofLife #GivingVoice2Patients #CancerResearch
📅 Thurs 23 Oct, 13:50 CT, Session 102: Hematology
Read more ➡️ www.eortc.org/blog/2025/10...
#QualityofLife #GivingVoice2Patients #CancerResearch
October 23, 2025 at 12:36 PM
🎤 Attending #ISOQOL 2025? Today, Kim Cocks will deliver an oral presentation on the update of the @eortc.org QLQ-MY20 module for multiple myeloma.
📅 Thurs 23 Oct, 13:50 CT, Session 102: Hematology
Read more ➡️ www.eortc.org/blog/2025/10...
#QualityofLife #GivingVoice2Patients #CancerResearch
📅 Thurs 23 Oct, 13:50 CT, Session 102: Hematology
Read more ➡️ www.eortc.org/blog/2025/10...
#QualityofLife #GivingVoice2Patients #CancerResearch
📣 Exciting news! @eortc.org, through its #QualityofLife (QoL) Group, is supporting #ISOQOL 2025 and will share insights into its latest QoL research through a series of impactful abstracts presented at the conference.
Learn more 👇
www.eortc.org/blog/2025/10...
#GivingVoice2Patients #CancerResearch
Learn more 👇
www.eortc.org/blog/2025/10...
#GivingVoice2Patients #CancerResearch
October 22, 2025 at 1:11 PM
📣 Exciting news! @eortc.org, through its #QualityofLife (QoL) Group, is supporting #ISOQOL 2025 and will share insights into its latest QoL research through a series of impactful abstracts presented at the conference.
Learn more 👇
www.eortc.org/blog/2025/10...
#GivingVoice2Patients #CancerResearch
Learn more 👇
www.eortc.org/blog/2025/10...
#GivingVoice2Patients #CancerResearch
Reposted by EORTC Quality of Life Group (QLG)
🙌 That’s a wrap on #ESMO25!
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
October 21, 2025 at 7:38 AM
🙌 That’s a wrap on #ESMO25!
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
👋 Attending #SIOPCongress this week?
📢 Catch tomorrow's presentation by @eortc.org #QualityofLife Group (QLG) member Anne-Sophie Darlington about a new EORTC QLG questionnaire aimed to measure all QoL issues of relevance and importance to AYAs aged 14-39 years with cancer.
@worldsiop.bsky.social
📢 Catch tomorrow's presentation by @eortc.org #QualityofLife Group (QLG) member Anne-Sophie Darlington about a new EORTC QLG questionnaire aimed to measure all QoL issues of relevance and importance to AYAs aged 14-39 years with cancer.
@worldsiop.bsky.social
October 20, 2025 at 1:44 PM
👋 Attending #SIOPCongress this week?
📢 Catch tomorrow's presentation by @eortc.org #QualityofLife Group (QLG) member Anne-Sophie Darlington about a new EORTC QLG questionnaire aimed to measure all QoL issues of relevance and importance to AYAs aged 14-39 years with cancer.
@worldsiop.bsky.social
📢 Catch tomorrow's presentation by @eortc.org #QualityofLife Group (QLG) member Anne-Sophie Darlington about a new EORTC QLG questionnaire aimed to measure all QoL issues of relevance and importance to AYAs aged 14-39 years with cancer.
@worldsiop.bsky.social
👏 Congratulations to our @eortc.org #QualityofLife Group members Veronika Engele & Louis Fox for their great presentations at #ESMO25.
🏅 And well done Veronika Engele for winning the ESMO 2025 Best Poster for Psycho-oncology! 💪
#CancerResearch #GivingVoice2Patients
@kingscollegelondon.bsky.social
🏅 And well done Veronika Engele for winning the ESMO 2025 Best Poster for Psycho-oncology! 💪
#CancerResearch #GivingVoice2Patients
@kingscollegelondon.bsky.social
October 19, 2025 at 2:35 PM
👏 Congratulations to our @eortc.org #QualityofLife Group members Veronika Engele & Louis Fox for their great presentations at #ESMO25.
🏅 And well done Veronika Engele for winning the ESMO 2025 Best Poster for Psycho-oncology! 💪
#CancerResearch #GivingVoice2Patients
@kingscollegelondon.bsky.social
🏅 And well done Veronika Engele for winning the ESMO 2025 Best Poster for Psycho-oncology! 💪
#CancerResearch #GivingVoice2Patients
@kingscollegelondon.bsky.social
Reposted by EORTC Quality of Life Group (QLG)
CSO was at #ESMO2025 today, hosting a symposium to discuss our work in advancing patient-centred cancer care, and how best to engage colleagues and the broader community in Europe and beyond.
#CommonSenseOncology #CancerCare
#CommonSenseOncology #CancerCare
October 17, 2025 at 8:04 PM
CSO was at #ESMO2025 today, hosting a symposium to discuss our work in advancing patient-centred cancer care, and how best to engage colleagues and the broader community in Europe and beyond.
#CommonSenseOncology #CancerCare
#CommonSenseOncology #CancerCare
Reposted by EORTC Quality of Life Group (QLG)
Reposted by EORTC Quality of Life Group (QLG)
👉 We continue this exciting day at #ESMO25 with a spotlight on patient engagement!
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
October 19, 2025 at 10:15 AM
👉 We continue this exciting day at #ESMO25 with a spotlight on patient engagement!
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
Reposted by EORTC Quality of Life Group (QLG)
👏 Well done to Denis Lacombe for a compelling session today at #ESMO25!
Together, we’re shaping a future of cancer research that’s smarter and more inclusive.
#EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social
Together, we’re shaping a future of cancer research that’s smarter and more inclusive.
#EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social
October 19, 2025 at 8:51 AM
👏 Well done to Denis Lacombe for a compelling session today at #ESMO25!
Together, we’re shaping a future of cancer research that’s smarter and more inclusive.
#EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social
Together, we’re shaping a future of cancer research that’s smarter and more inclusive.
#EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social
Reposted by EORTC Quality of Life Group (QLG)
Today at #ESMO25, EORTC CEO Denis Lacombe speaks on two key challenges in cancer research:
➡️ Are we using therapies optimally in real-world care?
➡️ Are clinical trials truly inclusive of all patients?
Two sessions, one goal: research that’s both effective and equitable.
#ClinicalTrials #DEI
➡️ Are we using therapies optimally in real-world care?
➡️ Are clinical trials truly inclusive of all patients?
Two sessions, one goal: research that’s both effective and equitable.
#ClinicalTrials #DEI
October 19, 2025 at 6:31 AM
Today at #ESMO25, EORTC CEO Denis Lacombe speaks on two key challenges in cancer research:
➡️ Are we using therapies optimally in real-world care?
➡️ Are clinical trials truly inclusive of all patients?
Two sessions, one goal: research that’s both effective and equitable.
#ClinicalTrials #DEI
➡️ Are we using therapies optimally in real-world care?
➡️ Are clinical trials truly inclusive of all patients?
Two sessions, one goal: research that’s both effective and equitable.
#ClinicalTrials #DEI
Reposted by EORTC Quality of Life Group (QLG)
👏 Huge congrats to Madeline Pe for her fantastic presentation at #ESMO25!
Sharing key outcomes from the SISAQOL-IMI initiative and putting patient voices at the heart of cancer research.
Proud moment for EORTC! 📸
#QualityOfLife #EORTC #CancerResearch #GivingVoice2Patients @qol.eortc.org
Sharing key outcomes from the SISAQOL-IMI initiative and putting patient voices at the heart of cancer research.
Proud moment for EORTC! 📸
#QualityOfLife #EORTC #CancerResearch #GivingVoice2Patients @qol.eortc.org
October 17, 2025 at 3:38 PM
👏 Huge congrats to Madeline Pe for her fantastic presentation at #ESMO25!
Sharing key outcomes from the SISAQOL-IMI initiative and putting patient voices at the heart of cancer research.
Proud moment for EORTC! 📸
#QualityOfLife #EORTC #CancerResearch #GivingVoice2Patients @qol.eortc.org
Sharing key outcomes from the SISAQOL-IMI initiative and putting patient voices at the heart of cancer research.
Proud moment for EORTC! 📸
#QualityOfLife #EORTC #CancerResearch #GivingVoice2Patients @qol.eortc.org
💪 Looking forward to the presentation by @madelinepe.bsky.social on the SISAQOL-IMI initiative shortly at #ESMO25!
#QualityofLife #GivingVoice2Patients
@eortc.org
#QualityofLife #GivingVoice2Patients
@eortc.org
👏 We’re proud to see Madeline Pe, Head of EORTC #QualityofLife Department, present key insights from the SISAQOL-IMI initiative at #ESMO25.
Four years of work to improve how patient-reported outcomes are analysed in cancer trials.
📢 Catch her talk today at 14:35 in Berlin!
@qol.eortc.org
Four years of work to improve how patient-reported outcomes are analysed in cancer trials.
📢 Catch her talk today at 14:35 in Berlin!
@qol.eortc.org
October 17, 2025 at 12:27 PM
💪 Looking forward to the presentation by @madelinepe.bsky.social on the SISAQOL-IMI initiative shortly at #ESMO25!
#QualityofLife #GivingVoice2Patients
@eortc.org
#QualityofLife #GivingVoice2Patients
@eortc.org
Reposted by EORTC Quality of Life Group (QLG)
ESMO 2025: A leadership moment!
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.
October 17, 2025 at 11:02 AM
ESMO 2025: A leadership moment!
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.